Ordering Recommendation

Optimize drug therapy and monitor patient adherence.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Timing of specimen collection: Predose (trough) draw at steady-state concentration.

Collect

Plain red.

Specimen Preparation

Separate serum from cells within 2 hours of collection. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated: Also acceptable: Room temperature or frozen.

Unacceptable Conditions

Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).

Remarks
Stability

Ambient: 48 hours; Refrigerated: 1 week; Frozen: 1 month
3 freeze/thaw cycles

Methodology

Quantitative Enzyme Immunoassay (EIA)

Performed

Sun-Sat

Reported

1-2 days

Reference Interval

Test Number
Components
Reference Interval
  Lacosamide, Serum
Therapeutic Range Toxic Range
1.0-10.0 ug/mL >=20.0 ug/mL

Interpretive Data

Lacosamide is an anticonvulsant drug indicated for adjunctive therapy for partial-onset seizures. The therapeutic range is based on serum, predose (trough) draw collection at steady-state concentration. Adverse effects may include dizziness, fatigue, nausea, vomiting, blurred vision, and tremor.

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

80235

Components

Component Test Code* Component Chart Name LOINC
3017895 Lacosamide, Serum 59297-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Lacosamide blood level
  • Vimpat
  • vimpat blood level
Lacosamide, Serum